Quantbot Technologies’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,659
Closed -$1.15M 2250
2025
Q3
$1.15M Buy
40,659
+32,265
+384% +$874K 0.03% 734
2025
Q2
$209K Sell
8,394
-15,412
-65% -$434K 0.01% 1222
2025
Q1
$738K Buy
23,806
+13,155
+124% +$438K 0.02% 770
2024
Q4
$336K Buy
10,651
+6,433
+153% +$306K 0.01% 937
2024
Q3
$244K Buy
4,218
+3,166
+301% +$156K 0.01% 999
2024
Q2
$42.7K Buy
+1,052
New +$41.7K ﹤0.01% 1276
2023
Q4
Sell
-3,428
Closed -$106K 2057
2023
Q3
$106K Sell
3,428
-3,641
-52% -$126K 0.01% 1076
2023
Q2
$223K Buy
+7,069
New +$242K 0.01% 934
2023
Q1
Sell
-7,218
Closed -$214K 2146
2022
Q4
$214K Sell
7,218
-16,467
-70% -$529K 0.02% 875
2022
Q3
$923K Buy
23,685
+22,271
+1,575% +$1.02M 0.07% 413
2022
Q2
$54K Buy
+1,414
New +$53.8K 0.01% 1293

Other funds holding ASTH

Quantbot Technologies's ASTH Position: Q4 2025 in Review

Quantbot Technologies sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 40,659 shares — an estimated $1.15M sold.

Quantbot Technologies first reported a position in ASTH in Q2 2022 and held it in 11 quarters. The position peaked at $1.15M in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Quantbot Technologies reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Quantbot Technologies sold 40,659 Astrana Health shares in Q4 2025, an estimated $1.15M.
  • Quantbot Technologies first reported a position in Astrana Health in Q2 2022 and held it in 11 quarters.
  • Quantbot Technologies's Astrana Health position peaked at $1.15M in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Quantbot Technologies's 13F filing for Q4 2025, filed 10 Feb 2026.